ReproCELL Launches New Culture Medium for High Quality Human Naïve iPS Cells, “ReproNaïveTM”

YOKOHAMA, Japan - ReproCELL (JASDAQ:4978) is pleased to announce that we will start selling new culture medium for high quality human iPS (naïve type) for the first time in the world, “ReproNaïveTM”, into which the most advanced iPS cell technology is introduced. Since Professor Shinya Yamanaka of Kyoto University pioneered iPS technology in 2006, iPS [...]

Tribogenics Introduces X-ray Industry’s First Sub-$10,000 Handheld XRF Analyzer for Metal Alloy Identification, Analysis and Testing

LOS ANGELES, Calif. — X-ray technology innovator Tribogenics, announced today that it has successfully commercialized the x-ray industry’s first sub $10,000 handheld XRF spectrometer using new proprietary X-ray technology. Handheld XRF analyzers have become the standard for non-destructive elemental analysis, testing and inspection in a wide range of industrial and consumer applications. Yet today, the [...]

Implant Sciences Selected in Competitive Bid to Supply 13 ETDs to a Second Airport in Belgium

WILMINGTON, Mass. -- Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 13 of its QS-B220 desktop explosives trace detectors to a second airport in Belgium. In a span of approximately two months, Implant Sciences has announced [...]

Crown Bioscience Expands Life Science Product Offering with Recombinant Cell Lines

Santa Clara, California -- Crown Bioscience, Inc., a leading global drug discovery and preclinical development service company announced that is has added cell lines for biological studies and oncology drug screening to their Life Science division’s catalog. Three new categories of cell lines are available for purchase: EML4-ALK Kinase-Live cell lines are Crown’s stable Ba/F3 [...]

SCIEX to Focus on the Educational Needs of Clinical Diagnostic Customers Following the Release of a Clinical Mass Spectrometry Market Trend Report

FRAMINGHAM, Mass. -- SCIEX, a global leader in life science analytical technologies, has released the results of an independent survey of clinical laboratories’ diagnostic technology usage that identifies a critical need for improved understanding of clinical mass spectrometry technology. The worldwide survey investigated the most commonly used diagnostic methods, technologies and assay types, and identified [...]

New Column Designed for Increased Sensitivity for Rapid LC/MS Analyses

GENEVA, SWITZERLAND – HPLC 2015 – A new column for liquid chromatography-mass spectrometry (LC/MS) analysis uses a unique capillary design to offer labs with limited samples and complex mixtures a fast and high-resolution solution for the identification of protein samples, facilitating high sensitivity proteomics and biotech applications. The Thermo Scientific ProSwift C4 RP-5H column incorporates [...]

CHEMRING SENSORS AND ELECTRONICS SYSTEMS ANNOUNCES PGR-1064™ HANDHELD RAMAN CHEMICAL, NARCOTIC AND EXPLOSIVE IDENTIFIER

Charlotte, NC – Chemring Detection Systems, Inc. (“CDS”), a subsidiary of Chemring Sensors & Electronic Systems (CSES) and part of Chemring Group PLC (“Chemring”), announces the launch of the PGR-1064™ handheld Raman chemical, narcotic and explosive identifier, designed for use in the field by HazMat, bomb squads, law enforcement, drug task forces and military personnel. [...]

RMC-Boeckeler Introduces LN-Ultra Cryosectioning System for Serial Section Applications

Tucson, AZ - In its beta test phase in late 2014, the LN-Ultra is now in production with its first public exhibition scheduled at the Microscopy & Microanalysis 2015 Meeting in Portland, Ore., Aug. 3-6, booth #867. The LN-Ultra is specifically designed for use with the RMC’s flagship PT-PC ultramicrotome, while the company’s legacy CRX [...]

Ampersand Capital Partners Acquires Protein Technologies, Inc.

Wellesley, Mass. and Tucson, Ariz. –– Ampersand Capital Partners, a private equity firm with a focus on growth equity investments in the healthcare sector, today announced the purchase of Protein Technologies, Inc., a leader in the field of peptide synthesis instrumentation. Terms of the transaction were not disclosed. The acquisition solidifies Protein Technologies’ financial position [...]

OGT launches comprehensive SureSeq Myeloid NGS Panel

Oxford Gene Technology (OGT), the molecular genetics company, today announces the launch of the SureSeq™ Myeloid Panel, a highly sensitive next generation sequencing (NGS) panel able to detect mutational changes in 25 genes in one comprehensive assay. The panel replaces the existing procedure of sequential analysis of single genes, to reduce the time and cost [...]

Access IBO on Knowledge Center